These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23375873)

  • 1. Shared dysregulated pathways lead to Parkinson's disease and diabetes.
    Santiago JA; Potashkin JA
    Trends Mol Med; 2013 Mar; 19(3):176-86. PubMed ID: 23375873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. System-based approaches to decode the molecular links in Parkinson's disease and diabetes.
    Santiago JA; Potashkin JA
    Neurobiol Dis; 2014 Dec; 72 Pt A():84-91. PubMed ID: 24718034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia is associated with insulin resistance in patients with Parkinson's disease.
    Bosco D; Plastino M; Cristiano D; Colica C; Ermio C; De Bartolo M; Mungari P; Fonte G; Consoli D; Consoli A; Fava A
    J Neurol Sci; 2012 Apr; 315(1-2):39-43. PubMed ID: 22265943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease, insulin resistance and novel agents of neuroprotection.
    Aviles-Olmos I; Limousin P; Lees A; Foltynie T
    Brain; 2013 Feb; 136(Pt 2):374-84. PubMed ID: 22344583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial pathology in Parkinson's disease.
    Schapira AH
    Mt Sinai J Med; 2011; 78(6):872-81. PubMed ID: 22069211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease.
    Tanaka M
    J Neurol; 2002 Sep; 249 Suppl 2():II11-8. PubMed ID: 12375058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.
    Soreq L; Ben-Shaul Y; Israel Z; Bergman H; Soreq H
    Neurobiol Dis; 2012 Mar; 45(3):1018-30. PubMed ID: 22198569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies.
    Bisaglia M; Greggio E; Beltramini M; Bubacco L
    FASEB J; 2013 Jun; 27(6):2101-10. PubMed ID: 23463698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ERcentric view of Parkinson's disease.
    Mercado G; Valdés P; Hetz C
    Trends Mol Med; 2013 Mar; 19(3):165-75. PubMed ID: 23352769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential biological mechanisms of arsenic-induced diabetes mellitus.
    Tseng CH
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):67-83. PubMed ID: 15163543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides.
    Dardiotis E; Xiromerisiou G; Hadjichristodoulou C; Tsatsakis AM; Wilks MF; Hadjigeorgiou GM
    Toxicology; 2013 May; 307():17-23. PubMed ID: 23295711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and Parkinson's disease: A new target for disease modification?
    Athauda D; Foltynie T
    Prog Neurobiol; 2016; 145-146():98-120. PubMed ID: 27713036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.
    Calì T; Ottolini D; Brini M
    Biofactors; 2011; 37(3):228-40. PubMed ID: 21674642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
    Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
    Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cellular iron dysregulation play a causative role in Parkinson's disease?
    Kaur D; Andersen J
    Ageing Res Rev; 2004 Jul; 3(3):327-43. PubMed ID: 15231240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.